...
首页> 外文期刊>Viral immunology >Effects of Risk Factors on Anti-HBs Development in Hepatitis B Vaccinated and Nonvaccinated Populations
【24h】

Effects of Risk Factors on Anti-HBs Development in Hepatitis B Vaccinated and Nonvaccinated Populations

机译:危险因素对乙肝疫苗接种人群和非疫苗接种人群抗HBs发生的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatitis B infection is still a major global health problem even though safe and effective vaccines have been available for more than 30 years. Although development of protective antibody to hepatitis B surface antigen (anti-HBs) is a common phenomenon after vaccination as well as natural infection, sometimes it does not appear even after complete vaccination. In the present study, whether the impairment of the development of anti-HBs in naturally infected and/or vaccinated populations is associated with immunomodulating risk factors (i.e., age, gender, smoking, and diabetes) and/or other risk factors (i.e., socioeconomic status, dental, and saloon exposure) was investigated through a cross-sectional study. Among 204 nonvaccinated patients, 132 (64.7%) tested positive for anti-HBc, indicating that they had been exposed to hepatitis B virus (HBV) at least once in their lifetime. Exposure to HBV (anti-HBc positive) was significantly higher among low-income people, dental exposed, and saloon users. Among anti-HBc positive patients, only 44 (33.3%) developed natural immunity with anti-HBs. Impairment in anti-HBs formation was found to be significantly high among cigarette smokers. However, no significant association of anti-HBs development was observed with age, gender, socioeconomic status, diabetes, dental exposure, and using saloon. Consistently, the frequency of developing protective anti-HBs (>= 10 IU/L) among a vaccinated population was almost nine times less among smokers. These data suggest that anti-HBs development, either naturally or after vaccination, is significantly lower among smokers. It emphasizes the need to check the anti-HBs status in smokers after vaccination, and a booster vaccination should be administered if the anti-HBs antibody titer decreases below the protective level.
机译:尽管安全有效的疫苗已经使用了30多年,但乙型肝炎感染仍然是全球主要的健康问题。尽管针对乙肝表面抗原(抗HBs)的保护性抗体的开发是疫苗接种以及自然感染后的常见现象,但有时甚至在完全疫苗接种后也不会出现。在本研究中,自然感染和/或接种疫苗的人群中抗HBs的发育障碍是否与免疫调节危险因素(即年龄,性别,吸烟和糖尿病)和/或其他危险因素(即社会经济状况,牙科和四门轿车的暴露)通过一项横断面研究进行了调查。在204名未接种疫苗的患者中,有132名(64.7%)的抗HBc检测呈阳性,表明他们一生中至少接触过一次乙型肝炎病毒(HBV)。在低收入人群,牙齿暴露者和四门轿车使用者中,HBV暴露(抗HBc阳性)显着更高。在抗HBc阳性患者中,只有44(33.3%)位患者对抗HBs具有天然免疫力。发现吸烟者中抗HBs形成的损害明显很高。但是,未观察到抗HBs的发展与年龄,性别,社会经济状况,糖尿病,牙齿暴露和使用轿车的相关性。一致地,在接种疫苗的人群中,产生保护性抗HBs(> = 10 IU / L)的频率几乎比吸烟者少9倍。这些数据表明,无论是自然的还是接种疫苗后,吸烟者的抗HBs发生率均显着降低。它强调需要在接种疫苗后检查吸烟者中的抗HBs状况,如果抗HBs抗体滴度降至保护水平以下,则应加强接种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号